16-30 of 1197
Assessing the Asthma Management Guideline Updates
The Drug ReportAssessing the Asthma Management Guideline Updates
Linda Bernstein, Pharm.D.
The FDA Expands Indication for Baloxavir Marboxil to Include Post-Exposure Influenza Prevention
The Drug ReportThe FDA Expands Indication for Baloxavir Marboxil to Include Post-Exposure Influenza Prevention
Linda Bernstein, Pharm.D.
A Look into the Development of a COVID-19 Vaccine
The Drug ReportA Look into the Development of a COVID-19 Vaccine
Linda Bernstein, Pharm.D.
Monoclonal Antibody Treatment for COVID-19 Receives FDA Authorization
The Drug ReportMonoclonal Antibody Treatment for COVID-19 Receives FDA Authorization
Linda Bernstein, Pharm.D.
Exploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19
The Drug ReportExploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19
Linda Bernstein, Pharm.D.
Measles Vaccination Rates Drop—But Pharmacists Can Help
The Drug ReportMeasles Vaccination Rates Drop—But Pharmacists Can Help
Linda Bernstein, Pharm.D.
- advertisement
CDC Playbook for COVID-19 Vaccine Distribution
The Drug ReportCDC Playbook for COVID-19 Vaccine Distribution
Linda Bernstein, Pharm.D.
FDA Approves Remdesivir, the First COVID-19 Treatment
The Drug ReportFDA Approves Remdesivir, the First COVID-19 Treatment
Linda Bernstein, Pharm.D.
Reopening Practices in Light of COVID-19
Perspectives with the AMAReopening Practices in Light of COVID-19
Matt Birnholz, MD
Carol Vargo, MHS
Sheryl Hirsch, MD, FAAP
Thomas Eppes, MD
Investigating the Circulation of Counterfeit COVID-19 Medications
COVID-19: On The FrontlinesInvestigating the Circulation of Counterfeit COVID-19 Medications
Charles Turck, PharmD, BCPS, BCCCP
Advocacy Efforts During the COVID-19 Pandemic
Perspectives with the AMAAdvocacy Efforts During the COVID-19 Pandemic
Jennifer Caudle, DO, FACOFP
Todd Askew
Perspectives on Responding Administratively to a Pandemic: Notes from a Children’s Hospital
COVID-19: On The FrontlinesPerspectives on Responding Administratively to a Pandemic: Notes from a Children’s Hospital
Matt Birnholz, MD
April Taylor, MS, MHA, CPPS, CPHQ
- advertisement
Artificial Intelligence’s Role in Combating the Antibiotic Resistance Crisis
Clinician's RoundtableArtificial Intelligence’s Role in Combating the Antibiotic Resistance Crisis
Paul Doghramji, MD
Jonathan Stokes
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
The Drug ReportThe DEA’s Adjustment to Schedule II Rules Amid COVID-19
Linda Bernstein, Pharm.D.
FDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19
The Drug ReportFDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19
Linda Bernstein, Pharm.D.